Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/140610 stock hub

XKON/140610 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/140610is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

178.8B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/140610

In the news

Latest news · XKON/140610

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-59.1

P25 n/aP50 n/aP75 n/a

ROIC-35.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/140610 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

KRW

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 178.8B
Price	KRW 13,200
Price currency	KRW
Sic	2836
Symbol	xkon/140610
Website	https://ensolbio.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.02%
FCF yield	-2.68%
P/B ratio	27.24x
P/S ratio	332.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	28.48%
Gross Profit	KRW 153M
Net Income	KRW -5.4B
Pretax Margin	-1,005.43%
ROA	-31.45
ROCE	-70.71
ROE	-59.14
ROIC	-35.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.09%
Cagr3y	3.23%
Cagr5y	-4.65%
Revenue Growth	208.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.05
Assets	KRW 7.6B
Cash	KRW 2.6B
Current Assets	KRW 2.9B
Current Liabilities	KRW 316.4M
Debt	KRW 30M
Debt Equity	KRW 0
Debt FCF	KRW -0.01
Equity	KRW 6.6B
Interest Coverage	-2,544.5
Liabilities	KRW 1.1B
Long Term Assets	KRW 4.8B
Long Term Liabilities	KRW 741M
Net Cash	KRW 2.6B
Net Cash By Market Cap	KRW 1.45
Net Debt Equity	KRW -0.39
Tangible Book Value	KRW 6.4B
Tangible Book Value Per Share	KRW 767
WACC	8.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.01
Net Working Capital	KRW -58.4M
Quick ratio	8.46
Working Capital	KRW 2.5B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-44.07%
200-day SMA	15,776.6
3Y total return	10%
50-day SMA	14,159.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.19%
All Time High	38,800
All Time High Change	-65.98%
All Time High Date	2025-07-01
All Time Low	2,800
All Time Low Change	371.43%
All Time Low Date	2024-03-22
ATR	883.2
Beta	0.68
Beta1y	0.27
Beta2y	0.61
Ch YTD	0.53
High	13,470
High52	38,800
High52 Date	2025-07-01
High52ch	-65.98%
Low	12,600
Low52	10,350
Low52 Date	2026-01-21
Low52ch	27.54%
Ma50ch	-6.78%
Price vs 200-day SMA	-16.33%
RSI	37.87
RSI Monthly	46.01
RSI Weekly	42.51
Sharpe ratio	-0.75x
Sortino ratio	-0.97
Tr YTD	0.53
Tr1m	-0.75%
Tr1w	-2.87%
Tr3m	6.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -5.2B
Operating margin	-961.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,094,809%
Net Borrowing	30,000,000
Shares Insiders	47.62%
Shares Out	13,546,020

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -5.1B
Average Volume	8,250.35x
Bv Per Share	782.3
CAPEX	KRW -142.8M
Ch1m	-0.75
Ch1w	-2.87
Ch1y	-44.07
Ch3m	6.28
Ch3y	10
Ch5y	-21.19
Ch6m	-10.51
Change	1.77%
Change From Open	2.09
Close	12,970
Days Gap	-0.31
Depreciation Amortization	398,383,350
Dollar Volume	143,998,800
EBIT	KRW -5.2B
EBITDA	KRW -4.8B
EPS	KRW -644
F Score	1
FCF	KRW -4.8B
FCF Per Share	KRW -354
Financing CF	30,000,000
Fiscal Year End	December
Founded	2,001
Investing CF	2,423,670,270
Is Primary Listing	1
Ma150	14,123.7
Ma150ch	-6.54%
Ma20	13,837.5
Ma20ch	-4.61%
Net CF	-2,199,525,730
Open	12,930
Position In Range	68.97
Ppne	4,249,156,780
Price Date	2026-05-08
Ptbv Ratio	27.78
Relative Volume	1.32x
Revenue	537,461,380x
SBC By Revenue	47.27x
Share Based Comp	254,057,100
Tr6m	-10.51%
Volume	10,909
Z Score	-7.18

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/140610 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/140610 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/140610?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+47.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/140610 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.9

Neutral momentum band

Price vs 200-day MA

-16.3%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

-0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/140610

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/140610 stock rating?

xkon/140610 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/140610 analysis?

The full report lives at /stocks/xkon/140610/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/140610?

The latest report frames xkon/140610 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/140610 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.